High IL‐10 levels during CRS are negatively associated with NK‐cell recovery after CAR‐T cell therapy
Abstract Objectives Immune reconstitution following chimeric antigen receptor (CAR)‐T cell therapy remains a critical clinical challenge, and the determinants of natural killer (NK)‐cell recovery are not fully understood. Methods We longitudinally monitored natural killer (NK)‐cell recovery in 64 patients during the fi...